- Home
- GRX vs FBRX Comparison
GRX vs FBRX Comparison
Compare GRX & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRX | FBRX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.6M | 379.3M |
| IPO Year | 2007 | 2017 |
Fundamental Metrics
Financial Performance| Metric | GRX | FBRX |
|---|---|---|
| Price | $9.58 | $27.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 40.6K | ★ 175.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.93 | $4.91 |
| 52 Week High | $10.15 | $35.62 |
Technical Indicators
Market Signals| Indicator | GRX | FBRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.79 | 41.36 |
| Support Level | $9.51 | $26.67 |
| Resistance Level | $9.69 | $32.12 |
| Average True Range (ATR) | 0.09 | 2.40 |
| MACD | -0.05 | -0.31 |
| Stochastic Oscillator | 7.14 | 10.74 |
Price Performance
Historical ComparisonAbout GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).